Monthly Archives: February 2009

FIBROMYALGIA AND PFIZER

From the Fibromyalgia (FMS) Global News Desk of Jeanne Hambleton

Pfizer, the manufacturers of Lyrica, the first fibromyalgia drug to be approved by the American Food & Drugs Associations (FDA), have decided to end human testing on a late-stage experimental drug, esreboxetine, which may have improved the cognitive function of patients with fibromyalgia. A second drug also to be withdrawn from the testing programme is associated with general anxiety problems. Both of these conditions are among the many symptoms of fibromyalgia.

The company announced it would stop further testing on these experimental primary care medications, now in the late stages of development, as they were other drugs available to treat these conditions.

The decision follows a move to ‘shift funding’ to alternative experimental drugs that have a greater profile.

The Wall Street Journal website, (http://blogs.wsj.com/health/2009/02/24/pfizer-drops-two-drugs-from-late-stage-pipeline/trackback/) overnight, on February 24, 2009, announced Pfizer Drops Two Drugs from Late-Stage Pipeline.

Sarah Rubenstein wrote two drugs in Pfizer’s late-stage pipeline are biting the dust.

The company said today it is ending development of esreboxetine, for fibromyalgia, and a drug known as PD 332,334, for generalized anxiety disorder.

In announcing the decision, Pfizer made a between-the-lines reference to the increasing pressure from insurers and regulators on the drug industry to pour research resources into products that make a real difference for people’s health rather than just add on to crowded categories. The economic-stimulus bill, for instance, offers up $1.1 billion for research comparing drugs and other treatments to each other.

Based on the data on the two drugs, “along with current market dynamics,” Pfizer said, “it was considered unlikely that either compound would provide meaningful benefit to patients beyond the current standard of care.” It added that safety was not the issue.

That said, there are not a lot of drugs on the market for fibromyalgia: Pfizer’s Lyrica was the first to win approval for fibromyalgia, and Lilly’s Cymbalta got the nod too. But fibromyalgia, a condition characterized by long-standing pain, has been the subject of controversy over its legitimacy, despite being recognized as a disease by the FDA and insurers.

Pfizer said today it is still seeking approval for Lyrica for generalized anxiety disorder, despite the demise of PD 332,334. In this case, though, there is a lot out there. The Mayo Clinic lists a bunch of drugs used for the disorder, including Cymbalta and Forest Labs’ Lexapro and generic versions of Lilly’s Prozac and GlaxoSmithKline’s Paxil.

Permalink | Trackback URL: http://blogs.wsj.com/health/2009/02/24/pfizer-drops-two-drugs-from-late-stage-pipeline/trackback/
Copyright ©2009 Dow Jones & Company, Inc. All Rights Reserved

‘Murky Disease” – FMA UK reponds to AP story

From the Fibromyalgia News Desk of Jeanne Hambleton

The Fibromyalgia Association UK
responding to the controversial ‘Murky Disease’ article published by Associated Press on February 9, 2009, wrote:

Many charities and nonprofit groups around the world have been struggling to raise awareness of fibromyalgia for over 20 years. Even before it was given that name, people were concerned that the symptoms were causing great distress and hardship to people who were inexplicitly in pain and suffering from profound bouts of fatigue.

One thing people with fibromyalgia are certain about is that the symptoms they feel are real and cannot be dismissed as “a murky illness” as this article suggests. Fibromyalgia was given validity long before the drug companies started their trials to find out if drugs they had developed could alleviate the symptoms. Most of the research into this disease would not have happened if it were not for drug companies supplying funding.

The organisations fighting for swift diagnosis and treatment for fibromyalgia have had very few allies. Certainly the medical services from government level to the doctors and nurses have not initiated plans for improving the situation. Long before the drugs approved in the USA were mooted as possibly bringing relief for people with fibromyalgia we had been seeking funding to help with the campaign for improvement. So this has not been pharma led, but in some cases pharma enabled.

In our case we had funding to print postcards for a campaign that we initiated to bring fibromyalgia to the attention of MPs and MEPs. These were offered to individuals who wanted their representatives to be more aware about the problems they are facing. It made it easier for people to invite their MPs to a coffee morning and the MEPs to a presentation for the recently passed European Written Declaration on Fibromyalgia.

We do not have any approved drugs in the UK or even Europe for the treatment of fibromyalgia. Indeed there are not even any official guidelines for its diagnosis and treatment. We have enquiries from the public and medical professionals asking us for information because they find this is not available when they are faced with a fibromyalgia patient.

We fundraise to be able to afford to print and distribute information and are very grateful to one sponsor who at present prints our general information booklet. This means we do not have make a charge for sending this out to people, which is especially appreciated by those who may have lost their income because of fibromyalgia. We would still publish and send this out without sponsorship: it would mean working harder at raising money instead of putting our energies into raising awareness or cutting back on other publications and support we provide.

If the drug companies did not help raise awareness of the disease and possible interventions, many more people would be left in pain, with a wretched quality of life. Fibromyalgia is not considered a life threatening illness, but we know of people that preferred to end their life rather than go on suffering the pain and fatigue for the rest of their lives. Would we rather that happened than funding was supplied from pharmaceutical companies to help?

Fibromyalgia Research News

From the Fibromyalgia FMS Global News Desk of Jeanne Hambleton

A service of the U.S. National Library of Medicine – NCBI – http://www.pubmed.gov
and the National Institutes of Health

Multidisciplinary care and stepwise treatment for fibromyalgia
J Clin Psychiatry. 2009 Feb 9;69(12):e35.

Arnold LM, Bradley LA, Clauw DJ, Glass JM, Goldenberg DL.
Division of Women’s Health Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Fibromyalgia is a common musculoskeletal pain condition associated with chronic widespread pain, tenderness at various points on the body, fatigue, sleep abnormalities, and common comorbidity with psychiatric and medical disorders. Research into pharmacologic remedies for fibromyalgia has demonstrated efficacy for a variety of agents, but pharmacology is only one piece of the puzzle when it comes to successful management of fibromyalgia. Sensitive and appropriate methods of diagnosis and an integrated treatment plan including proper patient education, aerobic exercise, and cognitive-behavioral therapy have been shown effective in alleviating fibromyalgic symptoms. The development of a comprehensive, multidisciplinary disease management strategy is a difficult but essential challenge facing clinicians treating patients with fibromyalgia. Copyright 2008 Physicians Postgraduate Press, Inc.

PMID: 19203485 [PubMed - in process] Courtesy of NCBI & PubMed

Assessing and diagnosing fibromyalgia in the clinical setting
J Clin Psychiatry. 2008 Nov 6;69(11):e33.

Clauw DJ.
Division of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

Fibromyalgia is a common and disabling condition that may be difficult to assess and diagnose owing to its wide range of symptoms and common comorbidities. The most common symptoms of fibromyalgia include widespread pain over the whole body, pain at specific tender points, fatigue, memory and other cognitive problems, sleep and mood disturbances, and impaired functioning. Accurately diagnosing fibromyalgia may require diagnostic testing and physical examinations such as tender points examinations; however, patients with longstanding symptoms may be diagnosed according to a symptom-based fibromyalgia criteria checklist. This activity provides a sample assessment and diagnosis in a clinical situation. Copyright 2008 Physicians Postgraduate Press, Inc.

PMID: 19200425 [PubMed - in process] Courtesy of NCBI & PubMed

Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions
Clin Rheumatol. 2009 Jan 27. [Epub ahead of print]

Okifuji A, Bradshaw DH, Olson C

Pain Research and Management Center, Department of Anesthesiology, University of Utah, 615 Arapeen Drive, Suite 200, Salt Lake City, UT, 84108, USA, akiko.okifuji@hsc.utah.edu.

The aim of this study was to investigate the associations between obesity and fibromyalgia syndrome (FMS). This study was conducted at the University of Utah Pain Management and Research Center, Salt Lake City, Utah. Thirty-eight FMS patients were included in this study. Neuroendocrine indices (catecholamines, cortisol, C-reactive protein [CRP], and interleukin-6), symptom measures (Fibromyalgia Impact Questionnaire), sleep indices (Actigraph), and physical functioning (treadmill testing) were measured. Body mass index (BMI) provided the primary indicator of obesity. Approximately 50% of the patients were obese and an additional 21% were overweight. Strong positive associations were found between BMI and levels of IL-6 (r = 0.52) and epinephrine (r = 0.54), and somewhat weaker associations with cortisol (r = 0.32) and CRP (r = 0.37). BMI was also related to maximal heart rate (r = 0.33) and inversely related to distance walked (r = -0.41). BMI was associated with disturbed sleep: total sleep time (r = -0.56) and sleep efficiency (r = -0.44). No associations between self-reported symptoms and BMI were found. This study provides preliminary evidence suggesting that obesity plays a role in FMS-related dysfunction.

PMID: 19172342 [PubMed - as supplied by publisher] Courtesy of NCBI & PubMed

Increased frequencies of hysterectomy and early menopause in fibromyalgia patients: a comparative study
Clin Rheumatol. 2009 Jan 24. [Epub ahead of print]

Pamuk ON, Dönmez S, Cakir N.

The objective was to determine the relationship between symptoms of fibromyalgia (FM) and early menopause and hysterectomy. We included 115 postmenopausal patients with FM (mean age 54.6 +/- 7.6) and 67 rheumatoid arthritis (RA) patients (mean age 55.5 +/- 9) into our study. All patients were questioned about the severity of their symptoms of FM, anxiety, and depression by using a visual analog scale and FM impact questionnaire. Patients’ history of menopause and hysterectomy were recorded. Menopause ( 0.05). FM-related symptoms started in 30 patients (26.1%) with FM with menopause or within the first postmenopausal year. When the clinical features of FM patients whose symptoms started within the first menopausal year were compared to other FM patients; it was observed that the frequency of early menopause was higher in the former group (p = 0.048). Duke anxiety and depression score was higher in patients with hysterectomy whose FM symptoms started within the first year of post-hysterectomy than other FM patients (9.1 +/- 2.7 vs. 6.7 +/- 2.7, p = 0.022). Early menopause and hysterectomy may be one of the factors contributing to the development of FM.

PMID: 19169621 [PubMed - as supplied by publisher] Courtesy of NCBI & PubMed

More ‘Murky Business’ – AP Report – A healthy dose of skepticism

From the Fibromyalgia FMS Global News Desk of Jeanne Hambleton

Letter to the Editor of trib.com :

 Thursday, February 19, 2009 11:01 PM MST

The Feb. 9 Associated Press article on fibromyalgia in the Star-Tribune was appropriately skeptical of the existence of a disorder that is nonspecific, has no known underlying cause, and has no confirmatory diagnostic test.

Fibromyalgia has, for years, been a “trash basket” diagnosis. Despite this, there are now medications approved for the treatment of this vague disorder — medications that are not only expensive but have potentially serious side effects.



Patients with fatigue, aching bones along with muscular weakness and pain or discomfort are often misdiagnosed with fibromyalgia, chronic fatigue syndrome, or other nonspecific disorders. While there are no tests to confirm a diagnosis of fibromyalgia, other conditions that may have similar symptoms should certainly be excluded before embarking on expensive and potentially dangerous and even ineffective drug therapy.

It is estimated that 40-60 percent of patients with “fibromyalgia” may have some component of vitamin D deficiency. Perhaps medications such as Cymbalta and Lyrica are appropriate for some individuals; however, a simple and relatively inexpensive blood test to rule out vitamin D deficiency should, at least, be considered before accepting a diagnosis of fibromyalgia.



Fibromyalgia may or may not be a real disorder, but until more much-needed scientific evidence becomes available to define it and support it as a unique entity, we should maintain a healthy skepticism and look for alternative diagnoses with simpler, safer remedies.

Vitamin D deficiency is epidemic in the U.S. and treatment is safe, inexpensive, and effective — often with dramatic symptomatic improvement. Doesn’t it, therefore, make sense to exclude this easily diagnosed but often unrecognized condition before joining the estimated 40-60 percent of patients with “fibromyalgia” who really have something else?



JAMES A. MADDY, M.D., Casper

Readers’ Comments

oldmunchkin wrote on Feb 20, 2009 1:42 AM:
” Its obvious Dr. Maddy does not suffer from this painful disease! Neither do I, but I do have a good friend who does. You do not even want to know how bad she feels on a bad day, it would make you cry with sympathy pains. It is obvious Dr. Maddy is one of those doctors who feels, if it cannot be seen on an X-ray, MRI, CAT scan, or found through blood work, it must not exist as a disease
As to the “OMG…the side effects” statement, what rubbish when the disease is MUCH worse than the side effects. Furthermore, I take one of these “horrible” drugs for a condition it has been “approved” for. The side effects are NOTHING compared to the pain I was in before. “

enlightenment wrote on Feb 20, 2009 12:24 PM:
” oldmunchkin – I did not come to same conclusion as you did from Dr. Maddy’s letter. Dr. Maddy did not say that people do not suffer from very painful symptoms. What he said is that these symptoms may be a result of a Vitamin D deficiency. You must not have read the letter very carefully. You should pass this info on to your friend. Maybe all she needs is Vitamin D.

Jennifer wrote on Feb 20, 2009 4:09 PM:
” Are you kidding me??? There is medical proof. MRI brain scans and spinal taps show abnormalities… obviously this doctor has NOT done is research or even done a simple Google search… I have been tested for vitamin D and my levels were great. “

Courtesy of trib.com – Wyoming’s online news source
Copyright © 1995–2008 Lee Enterprises – A subsidiary of Lee Enterprises Incorporated
(http://www.trib.com/articles/2009/02/20/editorial/letters/28a1944b0468b12d8725756200657704.txt)

New drug, Savella, brings hope for fibromyalgia patients

From the Fibromyalgia FMS Global News Desk of Jeanne Hambleton

By Marty Clear, Times Correspondent 
Posted: Feb 20, 2009 04:46 PM
Courtesy of tampabay.com St Petersburg Times

Hard to define and even harder to treat, fibromyalgia has become one of the most controversial medical conditions of the past quarter-century. Affecting an estimated 5.8 million Americans, it has been recognized as a disease by the American Medical Association since 1987. But because its most significant symptoms are pain and fatigue, with no obvious cause, FM patients — most of whom are women — can sometimes find that they’re not taken seriously even by some medical professionals.

St. Petersburg geriatrician and fibromyalgia expert Dr. Mildred Farmer says there’s new hope on the horizon for FM sufferers. Meridien Research, the company she co-founded in 1990, was one of the institutions that tested the efficacy and safety of a new fibromyalgia medication called Savella that was recently approved by the FDA and should be on the market later this year. It’s just the third anti-FM medication approved by the FDA, following Cymbalta and Lyrica.

Savella is already being prescribed in Europe as an antidepressant, but Meridien Research and other test sites across the country were looking at how it could help FM sufferers by affecting norepinephrine, a central nervous system neurotransmitter. Neither Farmer nor her company has a financial interest in Savella or the company that makes it, Cypress Bioscience.

What is fibromyalgia?

Essentially, it’s a collection of symptoms, a pain syndrome that is otherwise non-specific. Some people have aches and pains and not much fatigue, and some people have mostly the chronic fatigue and not as much pain. It could spring from a variety of causes.


How can you diagnose something that’s so elusive?

You must have widespread pain, in all four quadrants of the body, and it must be chronic. It’s characterized by the presence of trigger points. When you press on one of these points, they cause pain. It’s the presence of these trigger points and widespread pain, and the absence of joint and muscle pain, that makes fibromyalgia. It can be very subtle, and you might not even know you have it.

Who’s most likely to suffer from fibromyalgia?

It’s more common in women than men, and nobody knows why. I’ve read estimates that the ratio is 9 to 1. I wouldn’t be able to verify that, but it’s in that ballpark. Most of my fibromyalgia patients had a pain incident that preceded it — a car accident, a blow to the head. My usual patient is someone who has had back surgery. There’s also a genetic component, but it’s not just one gene, it’s a combination of genes.


How has it traditionally been treated?

What’s been happening for a long time is that rheumatologists have been treating fibromyalgia as a muscular-skeletal condition, and now it’s recognized as neuro-muscular. Traditional pain medications don’t do much. Non-steroidal anti-inflammatories, muscle relaxants, tricyclic antidepressants and exercise have all been somewhat effective, but different patients respond to different treatments. Even though the antidepressants can work, fibromyalgia is not depression. The patient may feel depressed, because of the chronic pain and because maybe no one believes her, but antidepressants can be effective for fibromyalgia itself.

Is Savella a dramatic breakthrough or just one more weapon in the arsenal?

In a way it’s just one more weapon. But the anti-fibromyalgia arsenal is so incredibly limited that even one additional weapon is significant.

What’s different about Savella?

Savella has more norepinephrine activity, and antidepressants with more norepinephrine activity seem to be more effective in treating pain. But there’s not been a head-to-head comparison of Cymbalta and this drug, so we can’t say this is better.

© 2009 · All Rights Reserved · St. Petersburg Times
490 First Avenue South · St. Petersburg, FL 33701 · 727-893-8111

http://www.tampabay.com/news/health/medicine/article977812.ece

Do You Have Fibromyalgia? Drug Company Hopes So

From the FMS Global News Desk of Jeanne Hambleton

Wednesday, 18 February 2009, Columnist – Martha Rosenberg

Even as new reports surface about alleged fake medical articles Pfizer planted to sell seizure drug Neurontin for unapproved uses from 1995 to 2002, it looks like deja vu all over again.

Pfizer gave nonprofits $2.1 million in grants in 2008 for medical courses about the pain-and-fatigue ailment fibromyalgia for which its Neurontin follow-up pill, Lyrica, just happens to be approved.

Lyrica (pregablin), facetiously called Son of Neurontin at Pfizer, was discovered by Northwestern University chemist Richard Silverman in 1989, earning the university a cool $700 million when it sold royalties in late 2007.

It is funding the $100 million Richard and Barbara Silverman Hall for Molecular Therapeutics & Diagnostics, under construction now, which will employ 245 faculty, staff and research assistants and hopefully lead to other promising molecules.

Like Neurontin (gabapentin), Lyrica (Pregablin) is an antiepilepsy drug (AED) that modulates calcium channels to dampen the excitability of nerve endings and seizure activity. And, like Neurontin which made $3 billion a year from unapproved uses like bipolar disorder, attention deficit disorder and restless legs syndrome, Pfizer has high hopes for its “crossover appeal.”

Lyrica was approved in 2006 for partial onset seizures and nerve pain associated with diabetes and shingles. But the FDA’s approval of Lyrica as the first drug for fibromyalgia in 2007 is what kicked sales up 37 percent in the third quarter to $465 million.

Fibromyalgia, with no clear cause, blood test, definition or cure “is almost a textbook definition of an unmet medical need,” enthused Pfizer VP Ian Read in a conference call to analysts when the drug first launched.

No kidding! Datamonitor predicts the fibro market can be “grown” from $400 million to $2 billion thanks to all the people who do not know they have it yet.

And even before the name Lyrica appeared, Pfizer’s initial “unbranded” campaign of public service announcements in conjunction with the National Fibromyalgia Association–are you listening broadcast executives? PSAs?– that featured people describing their symptoms and hawking the web site http://www.fibrohope.org moved script big time.

(Think Merck’s “unbranded” HPV vaccine Gardasil campaign.)

Despite a temporary Lyrica scare in 2001 when Pfizer had to freeze patient trials because mice developed cancerous tumors–luckily the rats did not–Lyrica was well received by the medical community.

Except they were all on the same team.

“Well tolerated,” said Pfizer paid doctors in Arthritis and Rheumatism in 2005.

“Proven efficacy” and “No new adverse events,” said Pfizer paid doctors in Drugs of Today in 2005 and 2007.

And, “Durability of effect for relieving FM pain,” said Pfizer paid doctors in the journal Pain in 2008.

Actual Lyrica users were less effusive, reporting memory loss, mental confusion, extreme weight gain, hair loss, impaired driving, disorientation, twitching and even two deaths on askapatient.com. And the FDA added suicide warnings to all AEDs in 2008.

Nor is the bad press over for Pfizer. The News Tribune reported Pfizer reps made over 200 visits to Western State Hospital, a mental hospital in Tacoma, Washington, within four years – “That is where our customers are,” snapped then company spokesman Bryant Haskins – where 118 prescriptions for Pfizer’s controversial drug Geodon were ordered in just one day.

And after paying $430 million in 2004 to settle Neurontin criminal charges, it agreed to pay $2.3 billion just last month for improper marketing of its painkiller, Bextra which was so dangerous it was withdrawn in 2005. Who can say incorrigible?

Few even noticed the repeat offense as Pfizer acquired rival Wyeth at the same time whose Fen Phen and Premarin travail make Pfizer’s profile look like Sir Galahad’s.

Hopefully, when Pfizer adds social phobia and general anxiety to conditions Lyrica can treat, it will remember to add headache. It will need a lot for itself.

Martha Rosenberg is a columnist/cartoon who writes about public health.

Courtesy New Zealand’s Independent News Media
(http://www.scoop.co.nz/stories/HL0902/S00309.htm)

Fibrobenefit – E-petition response

From the FMS Global News Desk of Jeanne Hambleton

I received this email from the Prime Minister’s Office at No.10 Downing Street, London, UK, today -

You signed a petition asking the Prime Minister to “Ease the pressure on
fibromyalgia sufferers and the benefits system including medical
assistance” - http://petitions.number10.gov.uk/Fibrobenefit/

“We the undersigned petition the Prime Minister to ease the pressure on fibromyalgia sufferers and the benefits system including medical assistance.”

“Gordon We ask for easier access to benefits within the DWP, Fibromyalgia sufferers are being pressured to produce too much evidence also, we are being asked to attend too many back to work pressure initiatives which compounded with excessive form filling causes flare-ups which does not allow us suitable calm to balance our condition which as you know has no cure. A Fibromyalgia sufferer would be happy to get out and about, work would be seen by many of us as a luxury, we really do not need to be pressured or lead before we are ready. Cheers for now Mark Manzie on behalf of those who suffer.”


Launched by Lisa Manzie, the petition ended in December with JUST 302 signatures.

Read the Government’s response


Thank you for signing this epetition and raising the concerns of Fibromyalgia sufferers in relation access to benefits and the work capability assessment.

The Work Capability Assessment

Individuals applying for Employment and Support Allowance will be asked to undertake a Work Capability Assessment. This is carried out by an independent healthcare professional, who assesses an individual’s functional capability. They then provide advice for a decision maker within the Department on the individual’s limited capability for work and limited capability for work related activity.

The Work Capability Assessment does not simply assess an individual’s capability on that day, but will take account of fluctuations in their condition. The healthcare professional will assess whether an individual is capable of carrying out an activity reliably and repeatedly the majority of the time. If this is not the case, then they are considered unable to carry it out at all. The advice which the healthcare professional provides to the decision maker therefore accurately reflects fluctuations in an individual’s condition, with respect to their frequency and duration.

Fluctuations are also accounted for in the provision of support. For example personal advisers are able to defer work-focused interviews where a claimant is too ill to participate at that time. In this way, Employment and Support Allowance operates as a personalised benefit, tailoring support to the individual.

The Work Capability Assessment focuses on the effect a person’s condition has on their capability for work, not on the condition itself.

Work-focused Interviews

Customers in receipt of a working age Jobcentre Plus benefit e.g. Incapacity Benefit or Employment and Support Allowance are required by law to attend a Work Focused Interview as a condition of continued entitlement to the full amount of benefit. However, where there is reason to believe that the customer would not benefit from the interview at the current time it may be deferred for a short period. Any deferral decision is made on an individual basis, takes account of the customer’s particular circumstances including the effect a person’s condition has on those circumstances, not on the condition itself and is at the discretion of the adviser.

The purpose of the Work Focused Interview is to help a customer identify appropriate job goals and establish what assistance is required to achieve them. The adviser works with the customer to agree an Action Plan. They would not expect the customer to participate in any activity until they were ready. One outcome may be attendance on a Condition Management Programme. The aim of the Condition Management Programme is to educate, support and advise customers on how best to manage their condition and to improve their functional ability.

For Incapacity Benefit or Employment and Support Allowance customers, these interviews are conducted through the Pathways to Work Service which is specifically designed for people with a disability or health condition.

SHARE YOUR EXPERIENCE

What are your experiences? How did you do with your assessment? Tell me your ‘horror’ stories – let us talk. I need your name and email address and the town where you live – but will only print your first name and the town. Subject matter please – BENEFITS & No.10. Please share with us – it could help others.

If you are launching an e-petition about fibromyalgia please tell me and I will sign it, tell my friends and hopefully they will tell theirs. A mere 302 signatures out of at least 2 million fibromyalgia sufferers is a poor show – you must agree!

Okay so you did not know about this e-petition and some folks do not have access to the Internet, but I am trying to make changes –

email me at fmsglobalnews@me.com

with your e-petition link. It is over to you – we are all fighting the same battle – recognition – awareness and some funding from the Government for research.

SO YOU WANT TO DO YOUR OWN E-PETITION

How do you launch an e-petition? For UK residents only – log on to

http://petitions.number10.gov.uk/

It is really quite simple but you will be asked to consider if your message has already been printed on this website. This may mean some minor changes to your petition title and wording. It is a good idea to search for ‘fibromyalgia’ on the website before you finalise your e-petition.

Prepare the message on your desktop so you can spellcheck, cut and paste. Consider how long you want the e-petition to be active. You will need a closing date and their response will be sent to you automatically. Make a note of the website link address. Finally if you do not tell everyone about your e-petition, they will not sign it.

Add the e-petition link at the bottom of every email you send out, asking for support and please tell me. If you belong to a group make sure they know. Send details to the FMA UK website (www.fibromyalgia-associationuk.org/) and announce details on any forum you belong to.

You need 1,000s of signatures for any real impact although it appears they answer your petition with just 302 people signing.

Good luck and do not forget to let me know please – Jeanne at

fmsglobalnews@me.com


TELL YOUR MP

Why not send it to your MP? Who is he? Log on to

http://www.theyworkforyou.com/ with your post code

You can search for his/her postal address, email or whatever and send the link asking for your question to be raised by him in the House. They are back after half term from February 23rd. A fairly safe bet for an email address is surnameinitial@parliament.uk. There are exceptions but this works most of the time.

If this produces some exciting results from your MP and No. 10 do let me know. News is my business and I am doing this for the late News Editor Rick Usher – read About FMS Global News 2009 (top of the page). It is all voluntary I should add. Talk soon. Jeanne

Please excuse any typos – I do try but sadly fibro fog gets in the way…..

Drug makers’ push boosts ‘murky’ ailment – Part 2

From the FMS Global News Desk of Jeanne Hambleton
To the Editor of Associated Press and Business Writer Matthew Perrone

AP Associated Press IMPACT:
re: Drug makers’ push boosts ‘murky’ ailment -Washington on February 8 2009

Dear Sirs,

I read the article and then I was so angry wrote this….

Before I was told I had fibromyaliga I was an auxillary nurse and very active in everything I did. Then one day while at work I started feeling ill and my body hurt so badly, within a few hours it actually made me pass out. I was sent home and the next day felt so ill I booked an appointment to see the doctor.

The doctor sent me to the hospital and I had all sorts of tests even for Aids, all the tests and a lot of other things. The wait for some of them tests was so scarey and took a week – so it felt like forever. I have been pulled and pushed and then told I had a condition called fibromyalgia, of which I knew nothing. Then after that more things to try help sort the pain out…

I am going to now tell you what it feels like for me two have this. I am on a lot tablets including morphine. Some days i cannot walk down the stairs, let alone get back up them. I cannot bath on my own without my husband being there. My children have to finish brushing my hair sometime because my arms get heavier and heavier. That is my children doing this for their mum. It should be me looking after them.

Even with the silly pills I am in pain. Do you people think I like being like this? This pain I feel hurts so much it stops me from doing the things i love and used to love.

It is downgrading for me as a human being to be like this. Do you people not realise that most days I wonder why I just do not end my life as I cannot do the things I used to. Yeah that is what this makes me feel like saying right now.

I was so well and loved life until I got this condition. It is not right for people to say its NOT REAL WELL LET ME TELL YOU!!!! I would not even wish this on someone just so they experience the pain of someone with fibromyalgia; even just to get people to say, ‘Hey they are not lying. It is not in their head. Oh God, we are sorry it real pain these fibromites feel. Okay we are going to help.’

Do people like you not understand what it is like to be called a liar and told OH IT IS IN YOUR HEAD? Do you not know what it feels like for people to disbelive what we go through?

That article is so wrong, so very wrong. Instead of criticizing people with this condition why can’t someone create a bloody cure? Then I would love to go back to being pain free and looking after old people. I would love to go dancing and drinking and out with my children and play with my grandchild that is due in August.

Do you people not understand that when my grandchild born I might not even have the strength to hold that baby? Do you know how that feels? Do you not know how it feels being unable to hang your own washing out or finish cooking a meal or getting a drink? If this is not bad enough for us what about our families who have to see us struggling most of the time or when were having a bad day? What about them seeing the one they love in so much pain? My husband had to sit there watch as I scream with pain and begged him to help me but he does not know how? He has to carry me downstairs or upstairs just so I can use the toilet. Don’t you people understand that we do not like being like this? The pain is so bad sometimes. What do we have to do to make people understand and help us for God’s sake….

Donna Weetch of Portsmouth Hampshire UK.

Editor’s Note: We know we must endure the pain as there is no cure and no Government funding for research in the UK, but if only people understood, if only there was more public awareness- if only more GPs and doctors had been trained with knowledge of fibromyalgia – if only….

We will continue to try to move mountains, seek donations and raise funds for our own research programme and one day – I promise Donna – there will be a cure. Think positive. It can only get better.

If you, the readers, have any bright ideas or want to donate to our funds for research, write tome. Jeanne -fmsglobalnews@me.com

A ‘Murky Business’ – Yes it is REAL

AP Associated Press IMPACT:

Drug makers’ push boosts ‘murky’ ailment

Collated by Jeanne Hambleton FMS Global News Desk ©2009        

 

A ‘Murky Business’ – Yes it is REAL

AP Associated Press IMPACT:

Drug makers’ push boosts ‘murky’ ailment

Collated by Jeanne Hambleton FMS Global News Desk ©2009        

 

Business Writer Matthew Perrone for AP: Associated Press has  “set the cat among the pigeons” with his reference to fibromyalgia and ‘murky ailments’. Posted in Washington on February 8 2009, this article has the promise of the same reaction given to the infamous IS DISEASE REAL article on fibromyalgia that appeared in the New York Times.

 

The  above story by NY Times reporter Alex Berenson published January 14, 2008 can be read at  <http://www.nytimes.com/2008/01/14/health/14pain.htmlem&ex=1200459600&en=bac45d5aff5a17d7&ei=5087> 

 

The members of the fibromyalgia community who are somewhat sensitive about questions suggesting FMS is an imaginary illness, has risen to the bait and letters are flocking in from around the USA where the article was published and in the UK, where it has been given coverage by FMS Global News.

 

Matthew Perrone, a business writer, suggests huge sums of money were provided by two drug companies last year in an endeavor to raise awareness of a “murky illness” as well as boost the sales of their medication recently approved by the Food & Drugs Association (FDA.). The writer claims the drug companies have been “drowning out unresolved questions” …. “whether it is a real disease at all”. 

 

Oooophs. That went down like a lead balloon.

 

Matthew Perrone discovered that the two drug companies, Pfizer and Eli Lilly, have in the first nine months of 2008 donated upward of $6 million towards educational events and to supporting non-profit making medical conferences. He claims this sum is greater than funds given to Alzheimer’s and diabetes. Top priority for funding by Pfizer was for cancer, AIDS and the fibromyalgia. Similarly Eli Lilly favoured cancer, depression and fibromyalgia.

 

While reminding readers that the cause for fibromyalgia still not known, with no specific test to confirm diagnosis, patients often showed overlapping symptoms with other neurological diseases. He claimed the specialists are in no doubt about the pain these patients suffer but they cannot agree how it should be treated and what illness it actually is.

 

It is believed by many patients and doctors, says Matthew Perrone, that the actions of the drug manufacturers are helping to solved the mysteries of fibromyalgia within the medical profession. He does acknowledge that patients with fibromyalgia say doctors often disbelieved them claiming the pains are imaginary or “all in your head.”

 

The article addscritics say the companies are hyping fibromyalgia along with their treatments, and that the grant making is a textbook example of how drug makers unduly influence doctors and patients.”

 

Dr Frederick Wolfe, a member of the panel who helped to definite the criteria for fibromyalgia and adopt the name in 1990, suggests the drug companies are guilty of  “a little disease-mongering” to encourage patients to buy their medication. The business writer reports that the companies have been successful in the actions showing huge increases in sales and profits between 2007 and 2008 for Lyrica and Cymbalta –both approved for the treatment of fibromyalgia by the FDA. 

 

Responding to questions from the author the drug companies say their actions are “just the evolution of greater awareness” of a condition that has been poorly managed and neglected. 

 

The article includes the story of a patient taking both Cymbalta and Lyrica and three other medications. Describing her medicated condition as fibro fog she is quoted as saying she is so medicated she feels as though she is not here. Struggling to find money for her medication she claimed she is receiving free samples of Lyrica from the drug company representative to help her get through the month.

 

The article reports both drug companies spent of $125 million on advertising in the first nine months of 2008.

 

Grants from the drug companies are available for education for doctors, non-profit making groups and advocacy. Some of this money is used for research and patients outreach.

 

President of the USA National Fibromyalgia Association Lynne Matallana is quoted as saying lack funding would impact on patients’ care due to lack of money for medical education. Matthew Perrone claims that 40% of the funding for the $1.5 million a year Association’s operations is provided by corporate funds, like those given by Eli Lilly and Pfizer. Lynne Matallana who has fibromyalgia claimed she visited 37 doctors before being diagnosed.

 

In a Pfizer television commercial the drug company acknowledged fibromyalgia is real, but Matthew Perrone says the researchers report it is not that easy. The condition usually known as a syndrome, has been described as a disease, a collection of symptoms and even a behaviour disorder.

 

This description suggesting a behaviour disorder has caused some concern among the fibromyalgia community who insist it is not a mental disorder.

 

It is thought that up to 12million people in the USA may have fibromyalgia in the USA with a large percentage of them women.

 

Market research on behalf of the pharmaceutical industry indicated that possibly 50% of this number are not diagnosed said Dr. Daniel Clauw (University of Michigan).

 

Dr. Don Goldenberg (Tufts University) who has spent 30 years working with fibromyalgia claims it remains a “murky area”.  He said patients preferred to have a name for what ailed them.  It was suggested that while Dr. Goldenberg is a diagnosing patients he said a number of doctors no longer diagnosed FMS patients suggesting it is a “catchall covering a range of symptoms”.

 

A professor at the University of North Carolina Dr. Nortin Hadler believes identifying fibromyalgia can “doom” patients to endure suffering for the rest of their lifetime and just confirms to them that this is a condition with no cure.  Dr. Hadler said the likelihood for patients diagnosed with fibromyalgia improving was “pretty dismal”

 

His view was that fibromyalgia was not a medical disease but a psychological condition (‘having to do with the mind’). He believed therapy should be available instead of drugs and medication, to help patients “unlearn” their problem.

 

Dr. Clauw whose research has revealed patient’ brains reveal  “unusual activity” when suffering pain, confirms fibromyalgia is a legitimate disease and he had no time for experts who analyse definitions instead of helping patients.  He also agreed that the new drugs approved by the FDA do not work for all  patients.

 

This article is a summary of  a story published by AP Associated Press distributed by Google.  © 2009 The Associated Press. All rights reserved.

http://www.google.com/hostednews/ap/article/ALeqM5jZDQjkt1twJK_3GpRKJUbXZ_-oMwD967HPG81

 

Fibromyalgia is not ‘murky’ to millions of people who live with it

Letter to the Editor of CantonRep.com  Posted Feb 13, 2009 

 

I read with interest “Drug makers push boosts a ‘murky’ ailment” (Feb. 9). I am both a patient with fibromyalgia and a physician who specializes in this condition, so I find it incredible when the article refers to so-called experts who are skeptical that the diagnosis even exists and that drug makers are somehow responsible for perpetuating this condition. 



Fibromyalgia is not “murky” to the many millions of patients worldwide who have it, and to the thousands of doctors who diagnose and treat it. It is a real condition with its own insurance code, specific diagnostic criteria and proven helpful treatments. It is recognized by major medical and legal organizations, including the Food and Drug Administration. 



We have not found a cure yet, but ongoing research is necessary to help improve the quality of lives of those who suffer from this chronic disease. To date, the FDA has approved three medicines for treatment of fibromyalgia pain.

These so-called experts mentioned in the article do not believe fibromyalgia exists, thus they never diagnose or treat it. To me, no experience with this condition means no expertise. Fortunately for patients, there are many primary-care doctors and specialists  (in the USA) who understand, research and treat fibromyalgia: the true experts. 



Unlike the critics, these professionals have actual experience and skills in trying to improve lives affected by chronic pain and will prescribe approved medications, not blame drug makers or patients for the pain. The true experts may not be as vocal as the so-called experts, but their efforts to help those with fibromyalgia have spoken the loudest. 


MARK J. PELLEGRINO, M.D., 

JACKSON TOWNSHIP

Reproduced courtesy of CantonRep.com Connecting Stark County

(http://www.cantonrep.com/opinion/letters/x817675485/Fibromyalgia-isnt-murky-to-millions-of-people-who-live-with-it)

 

National Fibromyalgia Association’s Response to

AP Article on Drug Companies & Fibromyalgia

Fibromyalgia & CFS Blog Friday February 13, 2009

By Adrienne Dellwo, About.com Guide to Fibromyalgia & CFS

 

The inaccuracies of the recent AP report, Drug makers push boosts ‘murky’ illness, go even beyond what I pointed out in a recent blog. Here is the response from Lynne Matallana, president of the National Fibromyalgia Association:

“To the editors:

“The recent Associated Press story on fibromyalgia hardly qualifies as news; it merely regurgitates the same arguments that have been published in the past and offers the opinions of the same two men who have built careers out of drawing attention away from the hundreds of scientists who continue to make amazing scientific strides toward understanding the underlying cause(s) and pathophysiology of what fibromyalgia patients experience.

 

“By perpetuating this message, the article implies that it is more acceptable to debate names or labels for this “set of symptoms” and to point fingers at the usual “villains” (i.e.: pharma and the non-profits who accept money from them), than to focus on the millions of desperate patients who deserve to have a voice in the discussion.

 

“The fact is that credible medical institutions and organizations recognize fibromyalgia as a life-altering disease; the fact is that patients who suffer with FM depend on the medical system (including pharmaceutical companies) to help them inform the public that this is a very real illness and that they need treatments, including pharmaceutical agents, to help them get through each day and to look forward to some sort of quality of life in the future.

 

“This article misinforms readers in a way that undermines and victimizes innocent people. By telling only selective parts of the story the author is perpetuating misperceptions and making it difficult, if not impossible, for readers to grasp what is truly important: that we need to stop debating and pointing fingers and start asking why it is perceived as acceptable to stigmatize a patient population just because medical research has not yet provided us with all the information needed to understand that particular illness. Every illness seems to go through a stage of having to prove its legitimacy, but why should the patients be suspect during that phase of research?

 

“Why would AP print information that is simply not true – people with fibromyalgia are “more likely to have a history of mental illness and are economically disadvantaged?” That is totally false, as is the writer’s statement that the National Fibromyalgia Research Association received pharma money to fund Dr. Clauw’s functional MRI study. The money for all of the NFRA’s funded research came from the founder (the husband of a fibromyalgia patient), general donations, and revenue generated from a non-profit bingo game. (Yes, the FM community has had to rely on bingo games to fund our research!)

 

“How can we allow the system to fail millions of people whose only ‘fault’ is to have developed a devastating illness? Along with the rest of the fibromyalgia patient community, I look forward to the day when society (including the medical community, the media, and our government agencies) accepts the responsibility of treating fibromyalgia patients like any other group of chronically ill patients; when it is a given that fibromyalgia will be further studied, that treatments will be developed and made accessible to patients, that the media presents the facts rather than perpetuating threadbare controversies.

“Now that would be news worth printing.

“Sincerely,

“Lynne Matallana

President, National Fibromyalgia Association”

Courtesy About.com

http://chronicfatigue.about.com/b/2009/02/13/national-fibromyalgia-associations-response-to-ap-article-on-drug-companies-fibromyalgia.htm

 

A ‘Murky Business’. Yes it is REAL

http://fmsglobalnews.wordpress.com

 A FIBROMITE’S RESPONSE

 

To the Editor and Business Writer Matthew Perrone Associated Press (info@ap.org).

Dear Sirs,

It is with great distress that I have read the article that denies the existence of this truly horrible illness. I would like to stress firstly that I am not a previous sufferer of mental illness, although I am now being treated for depression, and I am from an economically secure background.

 

Just answer me one question, if this illness is all in my head, how come so many millions of us suffer from such similar symptoms. Are we transmitting then to each other telepathically? We do not suffer identical intensity of each symptom, some us have irritable bowel syndrome worse than others for instance, but we all suffer from unexplained severe pain, terrible tiredness and loss of the quality of our lives.

 

I, sir, am a qualified psychologist who for a long time thought I was going mad, especially as every test I had came back negative. To actually realise that the awful symptoms I was suffering were not a result of “being in my head” came as a great relief and if drug companies are making profits that can be used to find out what causes this and find a cure I say hallelujah!!!

 

Articles like this do nothing to help and indeed set us back and damage us immeasurably in our quest to be taken seriously and find a cure.

 

Yours in despair

Carolyn from Felpham, West Sussex. UK

 

 THE FIBROMYALGIA COMMUNITY RESPONDS

 TO ASSOCIATED PRESS ARTICLE

 

1. The Associated Press article by Matthew Perrone (February 8, 2009, “Drug makers’ push boosts ‘murky’ aliment) has drawn several comments.

Click here to read the article.

Click here to read the NFA’s response, as well as some comments by other readers.

To send a letter to AP business editor Kevin Noble or writer Matthew Perrone, email info@ap.org  (no attachments).

2. The NFA is in the process of contacting media outlets across the nation that published Mr. Perrone’s article. In addition to sharing the disappointment of the fibromyalgia community, our response provides accurate information about fibromyalgia, including the science behind fibromyalgia and the lack of research funding.

3. For a list of 10 ways to respond to negative and false Information about fibromyalgia, click here.

4. Several points made in the AP article were addressed by fibromyalgia experts on February 11, 2009 during a medical talk show produced by Patient Power. Guests included leading FM researcher Daniel Clauw, MD, professor of medicine in the Division of Rheumatology, University of Michigan Health System; Martha Beck, Ph.D., who has been diagnosed with fibromyalgia; and Lynne Matallana, president and founder of the National Fibromyalgia Association. Click here to listen.

5. The NFA has created two information sheets—the Fibromyalgia Fact Sheet and Recognition, Research and Science—for your reference and use in helping dispel misunderstandings about fibromyalgia.

Click here to view the Fibromyalgia Fact Sheet.

Click here to view an overview on Recognition, Research and Science.

6. In addition to a variety of articles about managing FM symptoms, overlapping conditions, and healthy lifestyle choices, the NFA’s 10-year anniversary issue (September-November 2007) includes a special section on the History of Fibromyalgia. Topics include:

The state of FM and how it has changed in the last 10 years

How changing perspectives on FM have impacted the specialties that focus on it  

How patients have succeeded in changing public perception of FM

The latest studies on medications commonly prescribed to treat FM. Click here 

 

Undermining the Validity of FM

Sharon WaldropDirector, Fibromyalgia Association of Michigan USA

 

My name is Sharon Waldrop. I am the Founder and Director of the Fibromyalgia Association of Michigan, a volunteer nonprofit organization. I am a patient living with fibromyalgia (FM) and I am deeply disappointed in the article that ran yesterday in the Free Press copied off the AP. I am writing to you to ask if you would do a story on fibromyalgia to provide a balanced report on fibromyalgia? 

I am very sad that the millions of people who are suffering and struggling every minute of every day with fibromyalgia never get a chance to give their viewpoint in the media. Instead articles are written to please editors who have a formula that dictates what type of story “gets attention” and therefore gets printed …never taking into consideration or caring about the ramifications that their message will have on millions of innocent people.


The ramifications are that more marriages crumble, friendships (i.e. support systems) end, people lose jobs, people are denied access to care because the opinions of a select few are given mass attention. Credible medical institutions like Johns Hopkins University, the University of Michigan, the National Institutes of Health, (just to name a few), recognize fibromyalgia as a life-altering disease. It is time to treat FM patients with respect. Millions of people suffer from FM.  Millions more are suffering too as they watch their loved one struggle. These people do not need to read stories that FM is not real. They need to read stories about the exciting medical advances in fibromyalgia like the brain imaging study done at the University of Michigan that concretely prove people’s brains with FM act differently than people without FM. 

They need to be given hope and given the treatment they deserve as a human being.

My group has over 800 members in the Metro Detroit area.  We provide support and education to people affected by fibromyalgia.  People come to me in tears because they don’t know where to go for help. I am pleased that for 11 years I have given people a place to go – even if it is just for one night a month. No human being should have to fight an illness and also fight with spouses, friends, employers and yes, even doctors that they are in disabling physical pain. The question is not why do we continue to undermine the validity of FM but why are people afraid to provide support to people suffering from the chronic pain of fibromyalgia?
 In this time of uncertainty in the world, people more than ever need hope and help. Please will you write a story to help your readers understand FM? On behalf of my group we would greatly appreciate it.

 

Is Fibromyalgia Real?
 Andrew Schorr -
Founder Patient Power

We could have predicted it. Naysayers who say that now there are three approved prescriptions medicines for fibromyalgia, a chronic pain syndrome, marketing is fueling hype hype about a condition some people say is all in a patient’s head.

Here we go again. The drug companies are always an easy target. When a drug is a success it can bring in more than a billion dollars a year. Treatments are costly and many people, including millions with no insurance or who are under insured, struggle to pay for them. So the pharmaceutical industry continues to have a public relations problem.

But none of that has anything to do with whether people, primarily women, are suffering with debilitating pain, pain that is effectively treated often by the approved medicines.

Critics including some doctors say that because there is no definitive test for fibromyalgia it is a disservice to rush to treatment with the new drugs when maybe some patients need psychotherapy instead. It is in the patient’s head.

I am not qualified to evaluate who needs the medicines and who does not. But I do know this: the FDA advisory panels and the FDA itself would not have approved the medicines, nor would the drug companies have invested hundreds of millions of dollars on clinic trials, if they had no effectiveness.

After approval the drug companies have hit the airwaves with television commercials and with websites trying to raises awareness for the condition and that there are approved treatments. They also have been funding education programs to connect rheumatologists, who know all about fibromyalgia, with many primary care doctors who don’t. And they are funding patient education in partnership with groups like the National Fibromyalgia Association, founded by a patient and an organization that has cried out for awareness and effective treatments for years.

Is this public and medical education effort a bad thing?

Some media reports suggest it is: getting doctors and the public in a tizzy about a phony or overused diagnosis fueled by greedy drug companies who want to make billions. Oh please! While one could argue such important issues should be debated, I think we should focus on how to help give suffering patients relief from their pain and celebrate that private industry has made huge investments to meet the need.

Do we need to sort out exactly who needs these treatments and who could benefit in other ways? Sure. But to cast the same old aspersions on the drug companies is unfair and if we keep skewering them one day we can kiss drug development goodbye. The next time you swallow a pill that helps, you ask yourself what the world would be like if no one invented or marketed products like that.

 

FIBROMYALGIA Painfully Real 

Frederic Porcase Physician,

Jacksonville USA

 

Monday’s article demeans all of us with fibromyalgia.

The horrible part was the “Mind over Matter?” stating, “Patients diagnosed with fibromyalgia are more likely to have a history of mental illness, be overweight and economically disadvantaged. Some doctors say their suffering may stem from difficult circumstances rather than disease.”

I run a support group for people with fibromyalgia, and that is not the case. We are all type “A” personalities who have been forced to change our lives due to this horrible disease/syndrome.

All of us would give up our “great” disability funds for the more profitable lives we were living before the chronic pain and fatigue. We may be overweight now, due to not being able to exercise, but this was not the case before the chronic pain and fatigue started not after the diagnosis.

We all had the symptoms years before we actually got a diagnosis. No, we are not hypochondriacs. Fibromyalgia is an invisible disease. Thank goodness we don not look as bad as we feel. Walk in our shoes just one day and then say we have a mental disorder.

Courtesy Opinion.jacksonville/com

http://jacksonville.com/opinion/letters_from_readers/2009-02-11/story/letters_from_readers

 

Utterly real

Letters Published: Tue, Feb. 10, 2009 

Taryn Oesch – Raleigh USA

 

I was diagnosed with fibromyalgia when I was 13 by a Duke rheumatologist. It was a struggle to get back to feeling healthy, but it was a relief to know that I wasn’t imagining my achiness and debilitating fatigue. I have always considered myself fortunate to live in a time when fibromyalgia is considered a real syndrome.

The Feb. 9 Associated Press article “Help or hype? Drug makers fibromyalgia grants raise questions,” however, made me realize we still have a way to go.

Apparently, there are still those who would question the diagnosis, despite the fact that it has helped many people. It disturbed me especially that the article seemed to sympathize with the skeptics. Having a complaint of “I’m very tired” is hard enough to try to explain to professors or employers. 

The only press those of us with fibromyalgia need is press that makes everyone more aware that yes, fibromyalgia is real and yes, its diagnosis is backed by medical research.

 

 

Courtesy The News&Observer

http://www.newsobserver.com/opinion/letters/story/1401086.html



READERS: If you are writing to the Editor of Associated Press or the Business Writer Matthew Perrone, please send a copy of the email to me. I am interested and would like to publish your comments. Thanks. Please write to fmsglobalnews@me.com.Jeanne 

 

 

 

To Take Your Vitamins or Not In Light of Recent News

From the FMS Global News Desk of Jeanne Hambleton 

Health Tip: To Take Your Vitamins or Not In Light of Recent News
By Elisabetta Politi, the nutrition director at the Duke Diet and Fitness Center 


Feb 13, 2009 - HealthNewsDigest.com) – DURHAM, NC — Wondering if you should toss those vitamins in your mouth or in the trash? The latest study suggests the latter might do you as much good when it comes to preventing chronic disease. While vitamins don’t appear to do any harm, their health benefits of reducing one’s risk of heart disease and cancer were found to be negligible in a recent study.

Another recent study found healthy kids don’t need to be popping the vitamins either.

And last year’s news reported no life-lengthening effects from taking vitamins A, C, E beta carotene and selenium.

Does that mean it’s time to ditch the supplements?

That depends, say Elisabetta Politi, the nutrition director at the Duke Diet and Fitness Center. 

“While vitamins are not meant to be magic bullets of prevention, most Americans have poor eating habits and don’t get the daily recommended allowance of most vitamins and minerals. That’s why we continue to recommend a well-balanced multi-vitamin. People are so confused. But vitamins are like insurance, and there’s no evidence that taking them is harmful.”

Multi-vitamins fortified with 800-1,000 international units (iu) of vitamin D are ideal. “We know about 50 percent of Americans don’t get enough vitamin D,” says Politi, and that’s a problem because low levels of that particular vitamin have been linked to osteoporosis, fibromyalgia, colon cancer, and gingivitis, as well as immune system disorders like rheumatoid arthritis, lupus and type 1 diabetes. 

However, vitamins cost money, and in this economy, with everyone looking to save their pennies, you can easily cut the expense and the daily pill popping. All you have to do is maintain a healthy diet. Here’s how:

Eat at least five servings of vegetables and fruits every day. 
Frozen vegetables are fine but fresh are even better (and possibly cheaper) when locally produced. Visit a local farmer’s market, join a local co-op or better yet, start a community garden in your area to get the most bang for your buck. 

Sweet vegetables like corn, carrots, yams and fruits reduce your cravings for sweets, while dark green leafy vegetables like spinach, kale and collard greens are packed with minerals like iron, potassium, zinc and calcium. Bright, deep-colored fruits contain vitamins, minerals and antioxidants too. “All of these are really important if you want to get your vitamins and minerals from foods rather than a pill,” she says. 

Aim for three servings a day of low-fat dairy products which are the best sources of calcium. One serving equals one cup of milk, one cup of yogurt or about an ounce of low-fat cheese. 

Make every attempt to balance your caloric intake with your caloric expenditure. Its the only way you’ll be able to either maintain your current weight or even lose some of the extra pounds you’ve been holding on to. 
“The bottom line is if you eat plenty of fruits and vegetables, lean protein and whole grains, your diet will provide you with the right mix of carbohydrate, fiber and healthy fats,” she says. 

Even with the best intentions, however, you may still need a multi-vitamin if you’re:

– a poor or picky eater
– a vegetarian, especially vegan who avoid animal products like milk, cheese and eggs;
– pregnant, trying to get pregnant or breast-feeding woman;
– following a restricted calorie diet;
– allergic to a particular food or have a medical condition that affects how your body absorbs or uses food, or you’ve undergone surgery on your digest tract. 

Politi says it’s important to check your multi-vitamin’s nutritional value , making sure it’s between 50-200 percent for each ingredient. “If, for example, it has 100 percent of vitamin A, then you know that it contains the recommended daily amount,” she says. Also, take your supplement with your main meal of the day to enhance absorption. And, be sure to look at the expiration date. “Just like medicines, vitamin supplements expire and some of their biological properties can be lost or diminished.”

 

Courtesy of http://www.HealthNewsDigest.com

Follow

Get every new post delivered to your Inbox.